½ÃÀ庸°í¼­
»óǰÄÚµå
1539358

ÇǺΠÀ庮 ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)

Skin Barriers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 230 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå¿¡ °üÇÑ ±¤¹üÀ§ÇÑ ¸®Æ÷Æ®¸¦ ¹ßÇàÇϸç, ÃËÁø·Â, »õ·Î¿î µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀÇ Ã¶ÀúÇÑ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. º» ¸®Æ÷Æ®´Â ½ÃÀå ±¸µµ¸¦ Á¾ÇÕÀûÀ¸·Î ÀÌÇØÇϰí, ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ½ÃÇàÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ÇǺΠÀ庮 ½ÃÀå ±Ô¸ð(2024³â) : 3¾ï 7,060¸¸ ´Þ·¯
  • ½ÃÀå ¿¹Ãø ±Ý¾×(2033³â) : 5¾ï 800¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2033³â) : 3.6%

ÇǺΠÀ庮 ½ÃÀå - Á¶»ç ¹üÀ§

ÇǺΠÀ庮 ½ÃÀå¿¡´Â ¿ÜºÎ ÀÚ±Ø, ¼öºÐ ¼Õ½Ç ¹× °¨¿°À¸·ÎºÎÅÍ ÇǺθ¦ º¸È£Çϱâ À§ÇØ °í¾ÈµÈ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Á¦Ç°¿¡´Â »óó Ä¡·á, ¿ä½Ç±Ý Ä¡·á, ÇǺΰú Ä¡·á µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ´Â À庮 Å©¸², Çʸ§, µå·¹½Ì Àç·á µîÀÌ Æ÷ÇԵ˴ϴÙ. ÇǺΠÁúȯÀÇ À¯º´·ü Áõ°¡, ÇǺΠ°Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, À庮 ±â¼úÀÇ ¹ßÀüÀÌ ÀÌ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇǺΠÀ庮Àº ÇǺÎÀÇ ¹«°á¼ºÀ» À¯ÁöÇϰí Ä¡À¯¸¦ ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ÀÇ·á¿Í °£È£ ¸ðµÎ¿¡¼­ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:

¼¼°è ÇǺΠÀ庮 ½ÃÀåÀº ¸¸¼º »óó ¹× ÇǺΠÁúȯÀÇ À¯º´·ü Áõ°¡, ÇǺΠ°Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, À庮 Á¦Ç° ó¹æÀÇ ¹ßÀü µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇǺΠÁúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ­ Àα¸ Áõ°¡µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ƯÁ¤ ÇǺΠ»óÅÂ¿Í ¿ëµµ¿¡ ¸Â´Â Çõ½ÅÀûÀ̰í È¿°úÀûÀÎ À庮 Á¦Ç°ÀÇ °³¹ßÀÌ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ÇǺΠÀ庮ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ȯÀÚ Áß½É Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

À¯¸ÁÇÑ ¼ºÀå¼¼¿¡µµ ºÒ±¸Çϰí, ÇǺΠÀ庮 ½ÃÀåÀº ³ôÀº Á¦Ç° ºñ¿ë°ú ´ëü Ä¡·á¹ýÀÇ Á¸Àç¶ó´Â ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­´Â °í°¡ÀÇ ÇǺÎÀ庮 Á¦Ç° °¡°ÝÀÌ º¸±Þ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇǺΠÀ庮ÀÇ È¿°ú´Â ÇǺΠÀ¯Çü°ú »óÅ¿¡ µû¶ó ´Þ¶óÁú ¼ö ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ ȯÀÚ °á°ú¿¡ Â÷À̰¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â Á¦Ç°ÀÇ È¿°ú¿Í ºñ¿ë È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸¿Í ÷´Ü ÇǺÎÀ庮 ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ±âȸ :

ÇǺΠÀ庮 ½ÃÀåÀº ±â¼ú Çõ½Å°ú ÀÇ·á ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. »ýüÀûÇÕ¼º Àç·áÀÇ °³¹ß, Á¢ÂøÁ¦ÀÇ Á¦Çü °³¼± µî ÇǺÎÀ庮 ±â¼úÀÇ ¹ßÀüÀº »õ·Î¿î ¼ºÀåÀÇ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇǺΠÀ庮 Á¦Ç° È®´ë¿Í °³ÀÎ ¸ÂÃãÇü ½ºÅ²ÄÉ¾î ¼Ö·ç¼ÇÀÇ Ã¤Åà Áõ°¡µµ ½ÃÀå ÀáÀç·Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, R&D ÅõÀÚ, ½ÅÁ¦Ç° ¹× °³¼±µÈ Á¦Ç° äÅÃÀº ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå È®´ë¸¦ ÃßÁøÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ¼¼°è ÇǺΠÀ庮 ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ÇǺΠÀ庮ÀÇ Ã¤ÅÃÀ» ÁÖµµÇϰí ÀÖ´Â ¿ëµµ¿Í Áö¿ªÀº?
  • ±â¼ú ¹ßÀüÀº ÇǺΠÀ庮 ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?
  • ÇǺΠÀ庮 ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
  • ¼¼°è ÇǺÎÀ庮 ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
  • Æ÷ÇÔ »çÇס¤Á¦¿Ü »çÇ×

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
  • Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ

Á¦4Àå ºÎ°¡ ±Ý¾× ÀλçÀÌÆ®

  • »ý»ê Àü·«
  • ¼ö·® ¼Òºñ
  • »ý»êºñ¿ë
  • ¿ä½Ç±Ý°ú ½ºÅ丶ÀÇ Áõ°¡
  • ¿¬±¸°³¹ß
  • ÆÄÀÌÇÁ¶óÀÎ Æò°¡
  • ƯÇ㠺м®
  • PESTEL ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®

Á¦5Àå ½ÃÀå ¹è°æ

  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ½ÃÀå ¿ªÇÐ

Á¦6Àå COVID-19 À§±â ºÐ¼®

  • COVID-19¿Í ¿µÇ⠺м®
  • 2024³â ½ÃÀå ½Ã³ª¸®¿À

Á¦7Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀåÀÇ ¼ö·®(À¯´Ö) ºÐ¼®

  • °ú°Å ½ÃÀå ¼ö·®(À¯´Ö) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ¼ö·®(À¯´Ö) ¿¹Ãø, 2024-2033³â
    • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®

Á¦8Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå - °¡°Ý ºÐ¼®

  • Áö¿ªº° °¡°Ý ºÐ¼® : Á¦Ç°º°
  • °¡°Ý ³»¿ª
    • Á¦Á¶¾÷ü ·¹º§
    • À¯Åë¾÷ü ·¹º§
  • ¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
  • °¡°Ý°áÁ¤ ÀüÁ¦

Á¦9Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, ¹é¸¸ ´Þ·¯) ºÐ¼®

  • °ú°Å ½ÃÀå ±Ý¾×(¹é¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ý¾×(¹é¸¸ ´Þ·¯) ¿¹Ãø, 2024-2033³â
    • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
    • Àý´ë¾× ±âȸ ºÐ¼®

Á¦10Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(À¯´Ö) ºÐ¼® : Á¦Ç°º°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(À¯´Ö) ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°, 2024-2033³â
    • ½ºÅ² ¹è¸®¾î ½ºÇÁ·¹ÀÌ
    • º¸½À ¹è¸®¾î Å©¸²
    • º¸È£ ¿¬°í
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°º°

Á¦11Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : ÀûÀÀÁõº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : ÀûÀÀÁõº°, 2024-2033³â
    • ¿ä½Ç±Ý¡¤Àå·ç
    • ¸¸¼º â»ó
    • ¿åâ
    • ÇǺΠ¹ßÁø°ú °Ç¼ºÇǺÎ
    • ¾ÆÅäÇÇ ÇǺο°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÀûÀÀÁõº°

Á¦12Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : À¯Åë ä³Îº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : À¯Åë ä³Îº°, 2024-2033³â
    • ±â°üÅõÀÚ°¡¿ë ÆÇ¸Å
    • ¼Ò¸Å ÆÇ¸Å
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : À¯Åë ä³Îº°

Á¦13Àå ¼¼°èÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ¼­·Ð
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(À¯´Ö) ºÐ¼® : Áö¿ªº°, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ý¾×(¹é¸¸ ´Þ·¯)°ú ¼ö·®(À¯´Ö) ºÐ¼®°ú ¿¹Ãø : 2024-2033³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦14Àå ºÏ¹ÌÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦16Àå À¯·´ÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦17Àå µ¿¾Æ½Ã¾ÆÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦18Àå ³²¾Æ½Ã¾ÆÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦19Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) ÇǺΠÀ庮 ½ÃÀå ºÐ¼®

Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • ½ÃÀå ºÐ¼® : ±â¾÷ °èÃþº°
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÀÔÁö ºÐ¼®

Á¦22Àå °æÀï ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀï »ó¼¼ Á¤º¸
    • Hollister Inc.
    • ConvaTech Inc
    • DermaRite Industries LLC
    • 3M
    • Coloplast Corp
    • Stryker
    • Integra Lifesciences Corp
    • Smith &Nephew
    • GOJO Industries
    • Medlline Industries
    • B Braun Melsungen AG
    • Sonoma Pharmaceuticals Inc
    • Welland Medical Ltd.
    • Essity

Á¦23Àå »ç¿ëµÇ´Â ÀüÁ¦ Á¶°Ç°ú µÎÀÚ¾î

Á¦24Àå Á¶»ç ¹æ¹ý

KSA 24.09.23

Persistence Market Research has recently published an extensive report on the global Skin Barriers market, providing a thorough analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a comprehensive understanding of the market landscape, helping stakeholders make informed decisions.

Key Insights:

  • Skin Barriers Market Size (2024E): USD 370.6 Mn
  • Projected Market Value (2033F): USD 508 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 3.6%

Skin Barriers Market - Report Scope:

The Skin Barriers market encompasses a range of products designed to protect the skin from external irritants, moisture loss, and infections. These products include barrier creams, films, and dressings used across various applications such as wound care, incontinence, and dermatological treatments. The market is driven by an increasing prevalence of skin conditions, growing awareness of skin health, and advancements in barrier technology. Skin Barriers play a critical role in maintaining skin integrity and promoting healing, making them essential in both medical and personal care settings.

Market Growth Drivers:

The global Skin Barriers market is propelled by several key factors, including the rising incidence of chronic wounds and skin disorders, increased awareness of skin health, and advancements in barrier product formulations. The growing aging population, which is more susceptible to skin issues, is also contributing to market expansion. The development of innovative and more effective barrier products that cater to specific skin conditions and applications is driving demand. Additionally, the rising adoption of skin barriers in various healthcare settings and the increasing focus on patient-centric care are fueling market growth.

Market Restraints:

Despite its promising growth, the Skin Barriers market faces challenges such as high product costs and the presence of alternative treatments. The cost of advanced skin barrier products can be a barrier for widespread adoption, especially in developing regions. Moreover, the effectiveness of skin barriers can vary based on individual skin types and conditions, leading to variability in patient outcomes. Addressing these challenges requires ongoing research to enhance product efficacy and cost-efficiency, as well as increased accessibility to advanced skin barrier solutions.

Market Opportunities:

The Skin Barriers market presents significant growth opportunities driven by technological innovations and increasing healthcare demands. Advances in skin barrier technology, such as the development of bio-compatible materials and improved adhesive formulations, are creating new avenues for growth. The expansion of skin barrier products in emerging markets and the increasing adoption of personalized skincare solutions are also contributing to market potential. Strategic partnerships, investments in R&D, and the introduction of new and improved products will be crucial for companies looking to capitalize on these opportunities and drive market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Skin Barriers market globally?
  • Which applications and regions are leading the adoption of Skin Barriers?
  • How are technological advancements reshaping the competitive landscape of the Skin Barriers market?
  • Who are the key players in the Skin Barriers market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Skin Barriers market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Skin Barriers market, such as Coloplast, ConvaTec, and Hollister Incorporated, are focusing on innovation, technological advancements, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in R&D to develop cutting-edge skin barrier products that enhance efficacy, improve patient outcomes, and ensure product safety. Partnerships with healthcare providers, research institutions, and technology firms are essential for expanding market reach and driving the adoption of advanced skin barrier solutions. Emphasizing patient-centric approaches, robust product development, and market-specific strategies are key for sustaining leadership in the rapidly evolving Skin Barriers market.

Key Companies Profiled:

  • Hollister Inc.
  • ConvaTech Inc
  • DermaRite Industries LLC
  • 3M
  • Coloplast Corp,
  • Stryker
  • Integra Lifesciences Corp
  • Smith & Nephew
  • GOJO Industries
  • Medlline Industries
  • B Braun Melsungen AG
  • Sonoma Pharmaceuticals Inc
  • Welland Medical Ltd.
  • Essity

Key Segments Covered in Skin Barriers Industry Research

Product:

  • Skin Barrier Sprays
  • Moisture Barrier Creams
  • Protective Ointments

Indication:

  • Incontinence and Ostomy
  • Chronic Wounds
  • Pressure Ulcers
  • Skin Rash and Dry Skin
  • Atopic Dermatitis

Distribution:

  • Institutional Sales
  • Retail Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Skin Barriers Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Production Strategy
  • 4.2. Volume Consumption
  • 4.3. Production Cost
  • 4.4. Increased Incontinence and Ostomy
  • 4.5. Research and Development
  • 4.6. Pipeline Assessment
  • 4.7. Patent Analysis
  • 4.8. PESTEL Analysis
  • 4.9. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Increasing Geriatric Population
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Development of Novel Products
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Spending on Targeted Therapies
    • 5.2.4. Increasing Prevalence of Incontinence and Ostomy
    • 5.2.5. Rising Demand for Aesthetic Treatments
    • 5.2.6. Growing Social Media Influence
    • 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
  • 6.2. 2024 Market Scenario

7. Global Skin Barriers Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Skin Barriers Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Price Break up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Skin Barriers Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Skin Barriers Sprays
    • 10.3.2. Moisture Barrier Creams
    • 10.3.3. Protective Ointments
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis By Product

11. Global Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
    • 11.3.1. Incontinence and Ostomy
    • 11.3.2. Chronic Wounds
    • 11.3.3. Pressure Ulcers
    • 11.3.4. Skin Rash and Dry Skin
    • 11.3.5. Atopic Dermatitis
  • 11.4. Market Attractiveness Analysis By Indication

12. Global Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channels

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channels, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channels, 2024-2033
    • 12.3.1. Institutional Sales
      • 12.3.1.1. Hospitals
      • 12.3.1.2. Specialty Clinics
      • 12.3.1.3. Long Term Care Centers
      • 12.3.1.4. Skilled Nursing Facilities
    • 12.3.2. Retail Sales
      • 12.3.2.1. Retail Pharmacies
      • 12.3.2.2. Drug Stores
      • 12.3.2.3. Online Sales
  • 12.4. Market Attractiveness Analysis By Distribution Channels

13. Global Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channels
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By Distribution Channels
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Distribution Channels
    • 14.8.2. Canada Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Distribution Channels

15. Latin America Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By Distribution Channels
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By Distribution Channels
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Distribution Channels
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Distribution Channels
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Distribution Channels

16. Europe Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By Distribution Channels
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By Distribution Channels
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Distribution Channels
    • 16.8.2. Italy Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Distribution Channels
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Distribution Channels
    • 16.8.4. U.K. Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By Distribution Channels
    • 16.8.5. Spain Skin Barriers Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By Distribution Channels
    • 16.8.6. BENELUX Skin Barriers Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By Distribution Channels
    • 16.8.7. Russia Skin Barriers Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By Distribution Channels

17. East Asia Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By Distribution Channels
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By Distribution Channels
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Skin Barriers Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Distribution Channels
    • 17.8.2. Japan Skin Barriers Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Distribution Channels
    • 17.8.3. South Korea Skin Barriers Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By Distribution Channels

18. South Asia Skin Barriers Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By Distribution Channels
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By Distribution Channels
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Skin Barriers Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Distribution Channels
    • 18.8.2. Indonesia Skin Barriers Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Distribution Channels
    • 18.8.3. Malaysia Skin Barriers Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Distribution Channels
    • 18.8.4. Indonesia Skin Barriers Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Distribution Channels

19. Oceania Skin Barriers Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By Distribution Channels
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By Distribution Channels
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Oceania Skin Barriers Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By Distribution Channels
    • 19.8.2. New Zealand Skin Barriers Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By Distribution Channels

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By Distribution Channels
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Indication
    • 20.4.4. By Distribution Channels
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Skin Barriers Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By Distribution Channels
    • 20.8.2. Turkiye Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By Distribution Channels
    • 20.8.3. South Africa Skin Barriers Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By Distribution Channels
    • 20.8.4. North Africa Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By Distribution Channels

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Hollister Inc.
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
    • 22.3.2. ConvaTech Inc
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
    • 22.3.3. DermaRite Industries LLC
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
    • 22.3.4. 3M
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
    • 22.3.5. Coloplast Corp
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
    • 22.3.6. Stryker
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview
    • 22.3.7. Integra Lifesciences Corp
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Strategy Overview
    • 22.3.8. Smith & Nephew
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Strategy Overview
    • 22.3.9. GOJO Industries
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Strategy Overview
    • 22.3.10. Medlline Industries
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Strategy Overview
    • 22.3.11. B Braun Melsungen AG
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Financials
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Strategy Overview
    • 22.3.12. Sonoma Pharmaceuticals Inc
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Financials
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Strategy Overview
    • 22.3.13. Welland Medical Ltd.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Financials
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Strategy Overview
    • 22.3.14. Essity
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Key Financials
      • 22.3.14.5. SWOT Analysis
      • 22.3.14.6. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦